Literature DB >> 22850464

Monoamine oxidase A and A/B knockout mice display autistic-like features.

Marco Bortolato1, Sean C Godar, Loai Alzghoul, Junlin Zhang, Ryan D Darling, Kimberly L Simpson, Valentina Bini, Kevin Chen, Cara L Wellman, Rick C S Lin, Jean C Shih.   

Abstract

Converging lines of evidence show that a sizable subset of autism-spectrum disorders (ASDs) is characterized by increased blood levels of serotonin (5-hydroxytryptamine, 5-HT), yet the mechanistic link between these two phenomena remains unclear. The enzymatic degradation of brain 5-HT is mainly mediated by monoamine oxidase (MAO)A and, in the absence of this enzyme, by its cognate isoenzyme MAOB. MAOA and A/B knockout (KO) mice display high 5-HT levels, particularly during early developmental stages. Here we show that both mutant lines exhibit numerous behavioural hallmarks of ASDs, such as social and communication impairments, perseverative and stereotypical responses, behavioural inflexibility, as well as subtle tactile and motor deficits. Furthermore, both MAOA and A/B KO mice displayed neuropathological alterations reminiscent of typical ASD features, including reduced thickness of the corpus callosum, increased dendritic arborization of pyramidal neurons in the prefrontal cortex and disrupted microarchitecture of the cerebellum. The severity of repetitive responses and neuropathological aberrances was generally greater in MAOA/B KO animals. These findings suggest that the neurochemical imbalances induced by MAOA deficiency (either by itself or in conjunction with lack of MAOB) may result in an array of abnormalities similar to those observed in ASDs. Thus, MAOA and A/B KO mice may afford valuable models to help elucidate the neurobiological bases of these disorders and related neurodevelopmental problems.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22850464      PMCID: PMC3517692          DOI: 10.1017/S1461145712000715

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  99 in total

Review 1.  Multivariate and nonlinear approaches to characterizing drug effects on the locomotor and investigatory behavior of rats.

Authors:  M A Geyer; M P Paulus
Journal:  NIDA Res Monogr       Date:  1992

2.  Specification of the phenotype required for men with monoamine oxidase type A deficiency.

Authors:  J Hebebrand; B Klug
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

3.  Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period.

Authors:  O Cases; T Vitalis; I Seif; E De Maeyer; C Sotelo; P Gaspar
Journal:  Neuron       Date:  1996-02       Impact factor: 17.173

Review 4.  The hyperserotonemia of autism.

Authors:  G M Anderson; W C Horne; D Chatterjee; D J Cohen
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

5.  Monoamines (serotonin and catecholamines) and their derivatives in infantile autism: age-related changes and drug effects.

Authors:  J Martineau; C Barthélémy; J Jouve; J P Muh; G Lelord
Journal:  Dev Med Child Neurol       Date:  1992-07       Impact factor: 5.449

6.  Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A.

Authors:  H G Brunner; M Nelen; X O Breakefield; H H Ropers; B A van Oost
Journal:  Science       Date:  1993-10-22       Impact factor: 47.728

7.  Noradrenergic and adrenergic functioning in autism.

Authors:  R B Minderaa; G M Anderson; F R Volkmar; G W Akkerhuis; D J Cohen
Journal:  Biol Psychiatry       Date:  1994-08-15       Impact factor: 13.382

8.  Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA.

Authors:  O Cases; I Seif; J Grimsby; P Gaspar; K Chen; S Pournin; U Müller; M Aguet; C Babinet; J C Shih
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

9.  Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes.

Authors:  J W Lenders; G Eisenhofer; N G Abeling; W Berger; D L Murphy; C H Konings; L M Wagemakers; I J Kopin; F Karoum; A H van Gennip; H G Brunner
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

10.  X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism.

Authors:  H G Brunner; M R Nelen; P van Zandvoort; N G Abeling; A H van Gennip; E C Wolters; M A Kuiper; H H Ropers; B A van Oost
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

View more
  46 in total

Review 1.  Developmental neurogenetics and multimodal neuroimaging of sex differences in autism.

Authors:  Christina Chen; John Darrell Van Horn
Journal:  Brain Imaging Behav       Date:  2017-02       Impact factor: 3.978

2.  XLID-causing mutations and associated genes challenged in light of data from large-scale human exome sequencing.

Authors:  Amélie Piton; Claire Redin; Jean-Louis Mandel
Journal:  Am J Hum Genet       Date:  2013-07-18       Impact factor: 11.025

3.  SRY interference of normal regulation of the RET gene suggests a potential role of the Y-chromosome gene in sexual dimorphism in Hirschsprung disease.

Authors:  Yunmin Li; Tatsuo Kido; Maria M Garcia-Barcelo; Paul K H Tam; Z Laura Tabatabai; Yun-Fai Chris Lau
Journal:  Hum Mol Genet       Date:  2014-09-28       Impact factor: 6.150

4.  Gene-environment interactions in antisocial behavior are mediated by early-life 5-HT2A receptor activation.

Authors:  Sean C Godar; Laura J Mosher; Simona Scheggi; Paola Devoto; Kelly M Moench; Hunter J Strathman; Cori M Jones; Roberto Frau; Miriam Melis; Carla Gambarana; Brent Wilkinson; M Graziella DeMontis; Stephen C Fowler; Marcelo P Coba; Cara L Wellman; Jean C Shih; Marco Bortolato
Journal:  Neuropharmacology       Date:  2019-02-01       Impact factor: 5.250

5.  Altered gene expression in early postnatal monoamine oxidase A knockout mice.

Authors:  Kevin Chen; Abbey Kardys; Yibu Chen; Stephen Flink; Boris Tabakoff; Jean C Shih
Journal:  Brain Res       Date:  2017-05-20       Impact factor: 3.252

6.  Monoamine oxidase A is highly expressed in classical Hodgkin lymphoma.

Authors:  Pei Chuan Li; Imran N Siddiqi; Anja Mottok; Eric Y Loo; Chieh Hsi Wu; Wendy Cozen; Christian Steidl; Jean Chen Shih
Journal:  J Pathol       Date:  2017-09-05       Impact factor: 7.996

7.  Prevention of Severe Hypoglycemia-Induced Brain Damage and Cognitive Impairment With Verapamil.

Authors:  David A Jackson; Trevin Michael; Adriana Vieira de Abreu; Rahul Agrawal; Marco Bortolato; Simon J Fisher
Journal:  Diabetes       Date:  2018-05-03       Impact factor: 9.461

8.  Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors.

Authors:  Laura J Mosher; Sean C Godar; Marc Morissette; Kenneth M McFarlin; Simona Scheggi; Carla Gambarana; Stephen C Fowler; Thérèse Di Paolo; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2018-02-16       Impact factor: 4.905

Review 9.  The serotonin system in autism spectrum disorder: From biomarker to animal models.

Authors:  C L Muller; A M J Anacker; J Veenstra-VanderWeele
Journal:  Neuroscience       Date:  2015-11-11       Impact factor: 3.590

Review 10.  The role of the serotonergic system at the interface of aggression and suicide.

Authors:  M Bortolato; N Pivac; D Muck Seler; M Nikolac Perkovic; M Pessia; G Di Giovanni
Journal:  Neuroscience       Date:  2013-01-16       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.